Tumortherapie bei HIV-Infektion

  • M. Schrappe
  • V. Diehl


Ende 1993 liegt die Zahl der HIV-Infizierten bei weltweit ca. 15 Mio., 1/5 davon mit Aids-Manifestationen. Die Abschätzung wird durch die unterschiedliche Meldepraxis in unterentwickelten Ländern und die uneinheitliche Handhabung der Aids-Definition erschwert, die um die pulmonale Tuberkulose, rezidivierende bakterielle Pneumonien und invasive Zervixkarzinome (seit dem 1.7.1993 in Europa gültig) sowie um HIV-infizierte Patienten mit weniger als 200 CD 4+-T-Lymphozyten (seit 1.1.1993 nur in den USA) erweitert wurde. In der BRD ist Ende 1993 von ca. 10800 Aids-Patienten und über 60000 HIV-Infizierten auszugehen.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. Adachi A, Fleming I, Burk RD, Ho GY, Klein RS (1993) Women with human immunodeficiency virus infection and abnormal Papanicolaou smears: a prospective study of colposcopy and clinical outcome. Obstet Gynecol 81:372–377PubMedGoogle Scholar
  2. Anonymous (1992) 1993 revised classification system for HIV infection and expanded surveillance case definition for Aids among adolescents and adults. MMWR Morb Mortal Wkly Rep 41:1–19Google Scholar
  3. Armenian HK, Hoover DR, Rubb S et al. (1993) Composite risk score for Kaposi’s sarcoma based on a case-control and longitudinal study in the Multicenter Aids Cohort Study (MACS) population. Am J Epidemiol 138:256–265PubMedGoogle Scholar
  4. Beral V, Peterman TA, Berkelman RL, Jaffe HW (1990) Kaposi’s sarcoma among persons with Aids: a sexually transmitted infection? Lancet 335:123–128PubMedCrossRefGoogle Scholar
  5. Beral V, Peterman T, Berkelman R, Jaffe H (1991) Aids-associated Non-Hodgkin’s lymphoma. Lancet 337:805–809PubMedCrossRefGoogle Scholar
  6. Bermudez MA, Grant KM, Rodvien R, Mendes F (1989) Non-Hodgkin’s Lymphoma in a population with or at risk for acquired immunodeficiency syndrome: indications for intensive chemotherapy. Am J Med 86:71–76PubMedCrossRefGoogle Scholar
  7. Bundesgesundheitsamt (1992) Bericht des Aids-Zentrums des Bundesgesundheitsamtes über aktuelle epidemiologische Daten 12Google Scholar
  8. Carde P, Noordijk EM, Hagenbeck A et al. (1993) Superiority of MOPP/ABV over EBVP in combination with involved field irradiation in unfavorable clinical stage MI Hodgkin’s disease: The EORTC-GPMC H7-U Randomized Trial. Proc Am Soc Clin Oncol X:X-XGoogle Scholar
  9. Crosato IM, Tirelli U, Vaccher E et al. (1993) Solid tumors associated with HIV infection. Minerva Med 84:89–94PubMedGoogle Scholar
  10. Fraire AE, Awe RJ (1992) Lung cancer in association with human immunodeficiency virus infection. Cancer 70:432–436PubMedCrossRefGoogle Scholar
  11. Gachupin-Garcia A, Selwyn PA, Budner NS (1992) Population-based study of malignancies and HIV infection among injecting drug users in a New York City methadone treatment program, 1985–91. Aids 6:843–848PubMedCrossRefGoogle Scholar
  12. Gill PS, Rarick M, McCutchan JA et al. (1991) Systemic treatment of Aids-related Kaposi’s sarcoma: results of a randomized trial. Am J Med 90:427–433PubMedGoogle Scholar
  13. Gisselbrecht C, Oksenhendler E, Tirelli U (1992) Human immunodeficiency virus-related lymphoma. Treatment with intensive combination chemotherapy. French-Italian Cooperative Group. Am J Med 95:188–196CrossRefGoogle Scholar
  14. Hessol NA, Katz MH, Liu JY, Buchbinder SP, Rubino CJ, Holmberg SD (1992) Increased incidence of Hodgkin disease in homosexual men with HIV infection. Ann Intern Med 117:309–311PubMedGoogle Scholar
  15. Hoover DR, Black C, Jacobson LP et al. (1993) Epidemiologic analysis of Kaposi’s sarcoma as an early and later Aids outcome in homosexual men. Am J Epidemiol 138:266–278PubMedGoogle Scholar
  16. Kaplan LD, Abrams DI, Feigal E, et al. (1989) Aids-associated Non-Hodgkin’s lymphoma in San Francisco. JAMA 261:719–724PubMedCrossRefGoogle Scholar
  17. Kaplan LD, Kahn JO, Crowe S (1991) Clinical and virologic effects of recombinant human granulocyte-macrophage colony-stimulating factor in patients receiving chemotherapy for Human Immunodeficiency Virus-associated Non-Hodgkin’s lymphoma: results of a randomized trial. J Clin Oncol 9:929–940PubMedGoogle Scholar
  18. Krown SE, Metroka C, Wernz JC, and the Aids Clinical Trials Group Oncology Committee (1989) Kaposi’s sarcoma in the acquired immune deficiency syndrome: a proposal for uniform evaluation, response, and staging criteria. J Clin Oncol 7:1201–1207PubMedGoogle Scholar
  19. Krown SE, Paredes J, Bundow D, Polsky B, Gold JWM, Flomenberg N (1992) Interferon-Á, zidovudine, and granulocyte-macrophage colony-stimulating factor: a phase I Aids clinical trials group study in patients with Kaposi’s sarcoma associated with Aids. J Clin Oncol 10:1344–1351PubMedGoogle Scholar
  20. Lemp GF, Hirozawa AM, Araneta MR, Young K, Nieri G (1991) Improved survival for persons with Aids in San Francisco (abstr.). In: 7th International Conference on Aids, Florence, 1991, Abstract Book vol 1, p 66Google Scholar
  21. Levine AM (1990) Lymphoma in acquired immunodeficiency syndrome. Sem Oncol 17:104–112Google Scholar
  22. Levine AM, Wernz JC, Kaplan L et al. (1991) Low-dose chemotherapy with central nervous system prophylaxis and zidovudine maintenance in Aids-related lymphoma. A prospective, multi-institutional trial. JAMA 266:84–88PubMedCrossRefGoogle Scholar
  23. Levine AM (1993) Aids-related malignancies: the emerging epidemic. J Natl Cancer Inst 85:1382–1397PubMedCrossRefGoogle Scholar
  24. Maggwa BN, Hunter DJ, Mbugua S, Tukei P, Mati JK (199) The relationship between HIV infection and cervical intraepithelial neoplasia among women attending two family planning clinics in Nairobi, Kenya. Aids 7:733–738Google Scholar
  25. Maiman M, Fruchter RG, Serur E, Levine PA, Arrastia CD, Sedlis A (1993) Recurrent cervical intraepithelial neoplasia in human immunodeficiency virus-seropositive women. Obstet Gynecol 82:170–174PubMedGoogle Scholar
  26. Mandelblatt JS, Fahs M, Garibaldi K, Senie RT, Peterson HB (1992) Association between HIV infection and cervical neoplasia: implications for clinical care of women at risk for both conditions. Aids 6:173–178PubMedCrossRefGoogle Scholar
  27. Manns A, Coté T, Biggar R, Blattner W, and the NACMR Study Group (1993) Excess risk of leukemia among persons with the acquired immune deficiency syndrome (Aids). Proc Am Soc Clin Oncol 12:51Google Scholar
  28. Monfardini S, Tirelli U, Vaccher E, Foa R, Gavosto F (1991) Hodgkin’s disease in 63 intravenous drug users infected with human immunodeficiency virus. Gruppo Italiano Cooperativo Aids & Tumori (GICAT). Ann Oncol 2, [Suppl 2]: 201–205PubMedGoogle Scholar
  29. Monfardini S, Crosato IM, Turnolo S et al. (1992) No different treatment policy for testicular germ cell tumors in patients with HIV infection. Proc ASCO 11:48Google Scholar
  30. Palefsky JM (1991) Human papillomavirus-associated anogenital neoplasia and other solid tumors in human immunodeficiency virus-infected individuals. Curr Opin Oncol 3:881–885PubMedCrossRefGoogle Scholar
  31. Penn I (1983) Lymphomas complicating organ transplantation. Transplant Proc 15:2790–2797Google Scholar
  32. Reynolds P, Saunders LD, Layefsky ME, Lemp GF (1993) The spectrum of acquired immunodeficiency syndrome (Aids)-associated malignancies in San Francisco, 1980–1987. Am J Epidemiol 137:19–30PubMedGoogle Scholar
  33. Roithmann S, Toledano M, Tourani JM et al. (1991) HIV-associated Non-Hodgkin’s Lymphomas: Clinical characteristics and outcome. The experience of the French Registry of HIV-associated tumors. Ann Oncol 2:289–295PubMedGoogle Scholar
  34. Roithmann S, Tourani JM, Gastaut JA et al. (1992) Hodgkin’s disease associated with HIV infection: clinical characteristics and development. French registry of tumors associated with HIV infection. Bull Cancer (Paris) 79:873–882Google Scholar
  35. Schrappe M, Pohl C, Tesch H, Diehl V (1991) Die HIV-assoziierten Non-Hodgkin-Lymphome. Med Klin 86:646–654Google Scholar
  36. Smith JR, Kitchen VS, Botcherby M et al. (1993) Is HIV infection associated with an increase in the prevalence of cervical neoplasia? Br J Obstet Gynaecol 100:149–53PubMedCrossRefGoogle Scholar
  37. Tirelli U, Errante D, Vaccher E et al. (1992 a) Hodgkin’s disease in 92 patients with HIV infection: the Italian experience. GICAT (Italian Cooperative Group on Aids & Tumors). Ann Oncol 3 [Suppl 4]: 69–72PubMedGoogle Scholar
  38. Tirelli U, Oksenhendler E, Vaccher E et al. (1992 b) Prospective study with combined low-dose chemotherapy and zidovudine for 37 patients with poor prognosis HIV-related non-Hodgkin’s lymphoma. In: 3rd European Conference on Clinical Aspects and Treatment of HIV Infection, March 12–13, Paris 1992, p 62Google Scholar
  39. Trattner A, Hodak E, David M, Sandbank M (1993) The appearance of Kaposi sarcoma during corticosteroid therapy. Cancer 72:1779–1783PubMedCrossRefGoogle Scholar
  40. Van Griensven GJP, Hessol NA, Stevens CE, Katz MH, Coutinho RA (1992) Progression of HIV infection among homosexual men in HBV vaccine cohorts in Amsterdam, New York City and San Francisco, 1978–1991 (abstr.) In: 8th International Conference on Aids 1992, Amsterdam, vol 1, Mol7Google Scholar

Copyright information

© Springer-Verlag Heidelberg 1996

Authors and Affiliations

  • M. Schrappe
  • V. Diehl

There are no affiliations available

Personalised recommendations